Literature DB >> 30291342

Presymptomatic testing of those at 25% risk of autosomal dominant neurodegenerative disease- testing team beware.

Martin B Delatycki1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30291342      PMCID： PMC6303263          DOI： 10.1038/s41431-018-0280-6

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  5 in total

1.  Recommendations for the predictive genetic test in Huntington's disease.

Authors:  R MacLeod; A Tibben; M Frontali; G Evers-Kiebooms; A Jones; A Martinez-Descales; R A Roos
Journal:  Clin Genet       Date:  2012-07-30       Impact factor: 4.438

2.  Predictive genetic testing for neurodegenerative conditions: how should conflicting interests within families be managed?

Authors:  Zornitza Stark; Jane Wallace; Lynn Gillam; Matthew Burgess; Martin B Delatycki
Journal:  J Med Ethics       Date:  2016-06-08       Impact factor: 2.903

3.  A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.

Authors:  E W Almqvist; M Bloch; R Brinkman; D Craufurd; M R Hayden
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

4.  Problems assessing uptake of Huntington disease predictive testing and a proposed solution.

Authors:  Roslyn J Tassicker; Betty Teltscher; M Kaye Trembath; Veronica Collins; Leslie J Sheffield; Edmond Chiu; Lyle Gurrin; Martin B Delatycki
Journal:  Eur J Hum Genet       Date:  2008-07-30       Impact factor: 4.246

5.  Reverse pre-symptomatic testing for Huntington disease: double disclosure when 25% at-risk children reveal the genetic status to their parent.

Authors:  Adeline Bonnard; Ariane Herson; Marcela Gargiulo; Alexandra Durr
Journal:  Eur J Hum Genet       Date:  2018-09-11       Impact factor: 4.246
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.